Corvus hawaiiensis isolate bCorHaw1 chromosome 12, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036357.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC125332172, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC125332172, transcript variant X8
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC125332172, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125332172, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125332172, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125332172, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125332172, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized LOC125332172, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125332172, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125331956, transcript variant X2
uncharacterized LOC125331956, transcript variant X4
uncharacterized LOC125331956, transcript variant X6
uncharacterized LOC125331956, transcript variant X1
uncharacterized LOC125331956, transcript variant X3
uncharacterized LOC125331956, transcript variant X5
uncharacterized LOC125331955, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
uncharacterized LOC125331955, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized LOC125331955, transcript variant X2
uncharacterized LOC125331955, transcript variant X4
carbohydrate sulfotransferase 5-like, transcript variant X3
carbohydrate sulfotransferase 5-like, transcript variant X1
carbohydrate sulfotransferase 5-like, transcript variant X2
carbohydrate sulfotransferase 5-like isoform X1
carbohydrate sulfotransferase 5-like isoform X2
transmembrane protein 231, transcript variant X2
transmembrane protein 231, transcript variant X1
GABA type A receptor associated protein like 2
gamma-aminobutyric acid receptor-associated protein-like 2
adenosine deaminase tRNA specific 1, transcript variant X2
adenosine deaminase tRNA specific 1, transcript variant X1
tRNA-specific adenosine deaminase 1 isoform X2
tRNA-specific adenosine deaminase 1 isoform X1
lysyl-tRNA synthetase 1, transcript variant X2
lysyl-tRNA synthetase 1, transcript variant X1
lysyl-tRNA synthetase 1, transcript variant X4
lysyl-tRNA synthetase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
telomeric repeat-binding factor 2-interacting protein 1
carbohydrate sulfotransferase 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
carbohydrate sulfotransferase 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
PH domain and leucine rich repeat protein phosphatase 2, transcript variant X2
PH domain and leucine rich repeat protein phosphatase 2, transcript variant X1
PH domain and leucine rich repeat protein phosphatase 2, transcript variant X3
PH domain leucine-rich repeat-containing protein phosphatase 2 isoform X2
PH domain leucine-rich repeat-containing protein phosphatase 2 isoform X1
PH domain leucine-rich repeat-containing protein phosphatase 2 isoform X3
adaptor related protein complex 1 subunit gamma 1, transcript variant X4
adaptor related protein complex 1 subunit gamma 1, transcript variant X3
adaptor related protein complex 1 subunit gamma 1, transcript variant X1
adaptor related protein complex 1 subunit gamma 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00576
zinc finger protein 821, transcript variant X5
zinc finger protein 821, transcript variant X1
zinc finger protein 821, transcript variant X3
zinc finger protein 821, transcript variant X2
zinc finger protein 821, transcript variant X4
zinc finger protein 821, transcript variant X6
zinc finger protein 821, transcript variant X7
IST1 factor associated with ESCRT-III, transcript variant X3
IST1 factor associated with ESCRT-III, transcript variant X4
IST1 factor associated with ESCRT-III, transcript variant X2
IST1 factor associated with ESCRT-III, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
IST1 factor associated with ESCRT-III, transcript variant X8
IST1 factor associated with ESCRT-III, transcript variant X6
IST1 factor associated with ESCRT-III, transcript variant X1
IST1 factor associated with ESCRT-III, transcript variant X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dihydroorotate dehydrogenase (quinone), mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments
zinc finger homeobox 3, transcript variant X2
zinc finger homeobox 3, transcript variant X1
zinc finger homeobox 3, transcript variant X3
zinc finger homeobox 3, transcript variant X4
zinc finger homeobox 3, transcript variant X5
uncharacterized LOC125331928, transcript variant X3
uncharacterized LOC125331928, transcript variant X2
uncharacterized LOC125331928, transcript variant X1
uncharacterized LOC125331928, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 7
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X1
WW domain containing E3 ubiquitin protein ligase 2, transcript variant X2
NEDD4-like E3 ubiquitin-protein ligase WWP2
nuclear factor of activated T cells 5, transcript variant X4
nuclear factor of activated T cells 5, transcript variant X2
nuclear factor of activated T cells 5, transcript variant X1
nuclear factor of activated T cells 5, transcript variant X3
nuclear factor of activated T cells 5, transcript variant X7
nuclear factor of activated T cells 5, transcript variant X6
nuclear factor of activated T cells 5, transcript variant X5
nuclear factor of activated T-cells 5 isoform X2
nuclear factor of activated T-cells 5 isoform X1
nuclear factor of activated T-cells 5 isoform X4
nuclear factor of activated T-cells 5 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
telomeric repeat binding factor 2, transcript variant X2
telomeric repeat binding factor 2, transcript variant X1
telomeric repeat binding factor 2, transcript variant X4
telomeric repeat binding factor 2, transcript variant X3
telomeric repeat-binding factor 2 isoform X1
telomeric repeat-binding factor 2 isoform X4
telomeric repeat-binding factor 2 isoform X2
telomeric repeat-binding factor 2 isoform X3
transmembrane emp24 domain-containing protein 6
nucleolar pre-rRNA processing protein NIP7
60S ribosome subunit biogenesis protein NIP7 homolog
component of oligomeric golgi complex 8, transcript variant X2
component of oligomeric golgi complex 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
conserved oligomeric Golgi complex subunit 8 isoform X2
conserved oligomeric Golgi complex subunit 8 isoform X1
vacuolar protein sorting-associated protein 4A
U3 small nucleolar RNA-associated protein 4 homolog
chromosome transmission fidelity factor 8
chromosome transmission fidelity protein 8 homolog
transport and golgi organization 6 homolog
transport and Golgi organization protein 6 homolog
5-hydroxyisourate hydrolase-like, transcript variant X1
5-hydroxyisourate hydrolase-like, transcript variant X2
5-hydroxyisourate hydrolase-like isoform X2
dysbindin domain containing 1, transcript variant X2
dysbindin domain containing 1, transcript variant X3
dysbindin domain containing 1, transcript variant X4
dysbindin domain-containing protein 1 isoform X2
dysbindin domain-containing protein 1 isoform X3
dysbindin domain containing 1, transcript variant X1
dysbindin domain-containing protein 1 isoform X1
differentially expressed in FDCP 8 homolog
FA complementation group A, transcript variant X1
FA complementation group A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
FA complementation group A, transcript variant X2
Fanconi anemia group A protein isoform X1
Fanconi anemia group A protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
spermatogenesis-associated protein 2-like protein
LOW QUALITY PROTEIN: sulfotransferase 2B1-like
SPG7 matrix AAA peptidase subunit, paraplegin
ankyrin repeat domain containing 11, transcript variant X1
ankyrin repeat domain containing 11, transcript variant X2
ankyrin repeat domain containing 11, transcript variant X3
ankyrin repeat domain-containing protein 11
solute carrier family 22 member 31, transcript variant X2
putative solute carrier family 22 member 31 isoform X2
solute carrier family 22 member 31, transcript variant X1
putative solute carrier family 22 member 31 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
acyl-CoA synthetase family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
malonate--CoA ligase ACSF3, mitochondrial isoform X1
malonate--CoA ligase ACSF3, mitochondrial isoform X2
malonate--CoA ligase ACSF3, mitochondrial isoform X3
acyl-CoA synthetase family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
malonate--CoA ligase ACSF3, mitochondrial isoform X4
CBFA2/RUNX1 partner transcriptional co-repressor 3, transcript variant X5
CBFA2/RUNX1 partner transcriptional co-repressor 3, transcript variant X4
CBFA2/RUNX1 partner transcriptional co-repressor 3, transcript variant X6
CBFA2/RUNX1 partner transcriptional co-repressor 3, transcript variant X2
CBFA2/RUNX1 partner transcriptional co-repressor 3, transcript variant X1
CBFA2/RUNX1 partner transcriptional co-repressor 3, transcript variant X3
PABPN1 like, cytoplasmic, transcript variant X2
embryonic polyadenylate-binding protein 2 isoform X2
PABPN1 like, cytoplasmic, transcript variant X1
embryonic polyadenylate-binding protein 2 isoform X1
trafficking protein particle complex subunit 2L
trafficking protein particle complex subunit 2-like protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: N-acetylgalactosamine-6-sulfatase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adenine phosphoribosyltransferase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
adenine phosphoribosyltransferase isoform X3
adenine phosphoribosyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
adenine phosphoribosyltransferase, transcript variant X4
adenine phosphoribosyltransferase, transcript variant X1
adenine phosphoribosyltransferase isoform X1
adenine phosphoribosyltransferase isoform X2
adenine phosphoribosyltransferase isoform X4
chromatin licensing and DNA replication factor 1
piezo type mechanosensitive ion channel component 1, transcript variant X1
piezo type mechanosensitive ion channel component 1, transcript variant X2
piezo type mechanosensitive ion channel component 1, transcript variant X3
piezo-type mechanosensitive ion channel component 1 isoform X1
piezo-type mechanosensitive ion channel component 1 isoform X2
piezo-type mechanosensitive ion channel component 1 isoform X3
cytochrome b-245 light chain, transcript variant X1
uncharacterized protein LOC125332201 isoform X1
cytochrome b-245 light chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger CCCH-type containing 18, transcript variant X2
zinc finger CCCH-type containing 18, transcript variant X1
zinc finger CCCH domain-containing protein 18 isoform X2
zinc finger CCCH domain-containing protein 18 isoform X1
cell death inducing DFFA like effector c, transcript variant X3
cell death inducing DFFA like effector c, transcript variant X1
cell death inducing DFFA like effector c, transcript variant X2
zinc finger protein, FOG family member 1
zinc finger protein 469, transcript variant X1
zinc finger protein 469, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
BTG3 associated nuclear protein, transcript variant X2
BTG3 associated nuclear protein, transcript variant X1
carbonic anhydrase 5A, transcript variant X2
carbonic anhydrase 5A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
carbonic anhydrase 5A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
carbonic anhydrase 5A, transcript variant X1
carbonic anhydrase 5A, mitochondrial isoform X1
carbonic anhydrase 5A, mitochondrial isoform X4
carbonic anhydrase 5A, mitochondrial isoform X3
carbonic anhydrase 5A, transcript variant X3
carbonic anhydrase 5A, mitochondrial isoform X2
large neutral amino acids transporter small subunit 1
kelch domain containing 4, transcript variant X3
kelch domain containing 4, transcript variant X2
kelch domain containing 4, transcript variant X4
kelch domain containing 4, transcript variant X5
kelch domain containing 4, transcript variant X1
kelch domain-containing protein 4 isoform X4
kelch domain-containing protein 4 isoform X3
kelch domain-containing protein 4 isoform X2
kelch domain-containing protein 4 isoform X1
zinc finger CCHC domain-containing protein 14
microtubule associated protein 1 light chain 3 beta
microtubule-associated proteins 1A/1B light chain 3B
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
KIAA0513 ortholog, transcript variant X5
KIAA0513 ortholog, transcript variant X4
KIAA0513 ortholog, transcript variant X2
KIAA0513 ortholog, transcript variant X1
KIAA0513 ortholog, transcript variant X6
KIAA0513 ortholog, transcript variant X3
uncharacterized protein KIAA0513 homolog isoform X1
uncharacterized protein KIAA0513 homolog isoform X2
Gse1 coiled-coil protein, transcript variant X2
Gse1 coiled-coil protein, transcript variant X1
Gse1 coiled-coil protein, transcript variant X3
Gse1 coiled-coil protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
DNA replication complex GINS protein PSF2
uncharacterized LOC125332106, transcript variant X2
uncharacterized LOC125332106, transcript variant X1
cytochrome c oxidase subunit 4 isoform 1, mitochondrial
dual specificity protein phosphatase 22-A-like, transcript variant X7
dual specificity protein phosphatase 22-A-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dual specificity protein phosphatase 22-A-like isoform X6
dual specificity protein phosphatase 22-A-like isoform X5
dual specificity protein phosphatase 22-A-like, transcript variant X5
dual specificity protein phosphatase 22-A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
dual specificity protein phosphatase 22-A-like, transcript variant X1
dual specificity protein phosphatase 22-A-like isoform X4
dual specificity protein phosphatase 22-A-like isoform X3
dual specificity protein phosphatase 22-A-like, transcript variant X2
dual specificity protein phosphatase 22-A-like, transcript variant X3
dual specificity protein phosphatase-like isoform X2
dual specificity protein phosphatase-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
methenyltetrahydrofolate synthetase domain containing, transcript variant X1
methenyltetrahydrofolate synthetase domain containing, transcript variant X2
methenyltetrahydrofolate synthase domain-containing protein isoform X1
methenyltetrahydrofolate synthase domain-containing protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC125332300, transcript variant X3
uncharacterized LOC125332300, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC125332300, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 7
hepatocyte nuclear factor 4-beta-like, transcript variant X2
hepatocyte nuclear factor 4-beta-like, transcript variant X3
hepatocyte nuclear factor 4-beta-like, transcript variant X1
hepatocyte nuclear factor 4-beta-like, transcript variant X5
hepatocyte nuclear factor 4-beta-like, transcript variant X6
hepatocyte nuclear factor 4-beta-like, transcript variant X4
hepatocyte nuclear factor 4-beta-like isoform X3
hepatocyte nuclear factor 4-beta-like isoform X2
hepatocyte nuclear factor 4-beta-like isoform X1
cysteine rich secretory protein LCCL domain containing 2
cysteine-rich secretory protein LCCL domain-containing 2
ubiquitin carboxyl-terminal hydrolase 10
kelch like family member 36, transcript variant X2
kelch like family member 36, transcript variant X3
kelch like family member 36, transcript variant X1
coactosin like F-actin binding protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
MTOR associated protein, eak-7 homolog, transcript variant X1
MTOR associated protein, eak-7 homolog, transcript variant X2
MTOR associated protein, eak-7 homolog, transcript variant X4
MTOR-associated protein MEAK7 isoform X1
MTOR-associated protein MEAK7 isoform X2
MTOR associated protein, eak-7 homolog, transcript variant X5
MTOR associated protein, eak-7 homolog, transcript variant X3
MTOR-associated protein MEAK7 isoform X3
ATPase secretory pathway Ca2+ transporting 2
calcium-transporting ATPase type 2C member 2
WAP four-disulfide core domain protein 1
potassium voltage-gated channel modifier subfamily G member 4, transcript variant X1
potassium voltage-gated channel modifier subfamily G member 4, transcript variant X2
potassium voltage-gated channel modifier subfamily G member 4, transcript variant X3
potassium voltage-gated channel modifier subfamily G member 4, transcript variant X4
potassium voltage-gated channel modifier subfamily G member 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
potassium voltage-gated channel modifier subfamily G member 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
potassium voltage-gated channel modifier subfamily G member 4, transcript variant X5
potassium voltage-gated channel subfamily G member 4
heat shock factor binding protein 1, transcript variant X2
heat shock factor binding protein 1, transcript variant X1
malonyl-CoA decarboxylase, mitochondrial
arylamine N-acetyltransferase, pineal gland isozyme NAT-10
arylamine N-acetyltransferase, liver isozyme-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
arylamine N-acetyltransferase, liver isozyme-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
arylamine N-acetyltransferase, liver isozyme-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
arylamine N-acetyltransferase, liver isozyme-like
arylamine N-acetyltransferase, pineal gland isozyme NAT-3
17-beta-hydroxysteroid dehydrogenase type 2
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X1
short-chain dehydrogenase/reductase family 42E member 1 isoform X1
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X2
short-chain dehydrogenase/reductase family 42E member 1 isoform X2
phospholipase C gamma 2, transcript variant X1
phospholipase C gamma 2, transcript variant X2
phospholipase C gamma 2, transcript variant X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X3
uncharacterized LOC125332360, transcript variant X2
uncharacterized LOC125332360, transcript variant X1
polycystin 1 like 2, transcript variant X1
polycystin 1 like 2, transcript variant X3
polycystin 1 like 2, transcript variant X2
polycystin 1 like 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
polycystic kidney disease protein 1-like 2 isoform X1
polycystic kidney disease protein 1-like 2 isoform X3
polycystic kidney disease protein 1-like 2 isoform X2
polycystic kidney disease protein 1-like 2 isoform X4
glycine cleavage system H protein, mitochondrial
protein phosphatase 1 regulatory subunit 3E
C-X9-C motif containing 2, transcript variant X2
C-X9-C motif containing 2, transcript variant X1
C-X9-C motif containing 2, transcript variant X3
C-X9-C motif containing 2, transcript variant X4
C-X9-C motif containing 2, transcript variant X6
C-X9-C motif containing 2, transcript variant X5
COX assembly mitochondrial protein 2 homolog
uncharacterized LOC125332351, transcript variant X2
uncharacterized LOC125332351, transcript variant X1
uncharacterized LOC125332351, transcript variant X3
MAF bZIP transcription factor, transcript variant X1
MAF bZIP transcription factor, transcript variant X2
NDRG family member 4, transcript variant X3
NDRG family member 4, transcript variant X4
NDRG family member 4, transcript variant X1
NDRG family member 4, transcript variant X2
NDRG family member 4, transcript variant X6
NDRG family member 4, transcript variant X5
DNA replication complex GINS protein PSF3
casein kinase 2 alpha 2, transcript variant X3
casein kinase 2 alpha 2, transcript variant X4
casein kinase 2 alpha 2, transcript variant X2
casein kinase 2 alpha 2, transcript variant X1
cilia and flagella associated protein 20, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
cilia and flagella associated protein 20, transcript variant X2
cilia- and flagella-associated protein 20 isoform X2
cilia- and flagella-associated protein 20 isoform X1
zinc finger protein 319, transcript variant X1
zinc finger protein 319, transcript variant X3
zinc finger protein 319, transcript variant X2
cyclic nucleotide gated channel subunit beta 1
cyclic nucleotide-gated cation channel beta-1
kinesin family member C3, transcript variant X2
kinesin family member C3, transcript variant X1
kinesin family member C3, transcript variant X3
kinesin family member C3, transcript variant X4
kinesin family member C3, transcript variant X5
kinesin family member C3, transcript variant X6
kinesin family member C3, transcript variant X7
kinesin family member C3, transcript variant X8
katanin regulatory subunit B1, transcript variant X3
katanin regulatory subunit B1, transcript variant X2
katanin regulatory subunit B1, transcript variant X1
katanin p80 WD40 repeat-containing subunit B1 isoform X2
katanin p80 WD40 repeat-containing subunit B1 isoform X1
dynein regulatory complex subunit 7, transcript variant X2
dynein regulatory complex subunit 7, transcript variant X1
dynein regulatory complex subunit 7, transcript variant X4
dynein regulatory complex subunit 7, transcript variant X3
dynein regulatory complex subunit 7 isoform X2
dynein regulatory complex subunit 7 isoform X3
dynein regulatory complex subunit 7 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adhesion G protein-coupled receptor G3-like, transcript variant X6
adhesion G protein-coupled receptor G3-like, transcript variant X2
adhesion G protein-coupled receptor G3-like, transcript variant X5
adhesion G protein-coupled receptor G3-like, transcript variant X3
adhesion G protein-coupled receptor G3-like, transcript variant X4
adhesion G protein-coupled receptor G3-like, transcript variant X1
adhesion G protein-coupled receptor G3-like, transcript variant X7
adhesion G protein-coupled receptor G3-like isoform X6
adhesion G protein-coupled receptor G3-like isoform X2
adhesion G protein-coupled receptor G3-like isoform X5
adhesion G-protein coupled receptor G2-like isoform X3
adhesion G protein-coupled receptor G3-like isoform X4
adhesion G protein-coupled receptor G3-like isoform X1
adhesion G protein-coupled receptor G3-like isoform X7
adhesion G protein-coupled receptor G3-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adhesion G protein-coupled receptor G3-like isoform X8
coiled-coil domain containing 102A, transcript variant X3
coiled-coil domain containing 102A, transcript variant X2
coiled-coil domain containing 102A, transcript variant X1
coiled-coil domain-containing protein 102A
docking protein 4, transcript variant X1
docking protein 4, transcript variant X2
DNA-directed RNA polymerase II subunit RPB3
ubiquinone biosynthesis protein COQ9, mitochondrial isoform X2
ubiquinone biosynthesis protein COQ9, mitochondrial isoform X1
uncharacterized LOC125332264, transcript variant X2
uncharacterized LOC125332264, transcript variant X4
uncharacterized LOC125332264, transcript variant X1
uncharacterized LOC125332264, transcript variant X3
uncharacterized protein LOC125332264 isoform X3
uncharacterized protein LOC125332264 isoform X1
uncharacterized protein LOC125332264 isoform X2
glucose-fructose oxidoreductase domain containing 2, transcript variant X1
glucose-fructose oxidoreductase domain containing 2, transcript variant X2
glucose-fructose oxidoreductase domain-containing protein 2
enkurin domain containing 1, transcript variant X1
enkurin domain containing 1, transcript variant X4
enkurin domain containing 1, transcript variant X2
enkurin domain containing 1, transcript variant X3
par-6 family cell polarity regulator alpha, transcript variant X2
par-6 family cell polarity regulator alpha, transcript variant X1
partitioning defective 6 homolog alpha isoform X2
partitioning defective 6 homolog alpha isoform X1
homocysteine inducible ER protein with ubiquitin like domain 1
homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein
cholesteryl ester transfer protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cholesteryl ester transfer protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cholesteryl ester transfer protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cholesteryl ester transfer protein isoform X1
cholesteryl ester transfer protein isoform X2
cholesteryl ester transfer protein isoform X3
NLR family CARD domain containing 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
NLR family CARD domain containing 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
proteasome activator subunit 3 interacting protein 1, transcript variant X2
proteasome activator subunit 3 interacting protein 1, transcript variant X1
ring finger and SPRY domain containing 1, transcript variant X1
ring finger and SPRY domain containing 1, transcript variant X2
RING finger and SPRY domain-containing protein 1
ADP ribosylation factor like GTPase 2 binding protein
ADP-ribosylation factor-like protein 2-binding protein
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
RAN binding protein 10, transcript variant X1
RAN binding protein 10, transcript variant X2
RAN binding protein 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
protein serine kinase H1, transcript variant X1
protein serine kinase H1, transcript variant X2
exocyst complex component 3 like 1, transcript variant X2
exocyst complex component 3 like 1, transcript variant X1
exocyst complex component 3-like protein isoform X2
exocyst complex component 3-like protein isoform X1
E2F transcription factor 4, transcript variant X1
E2F transcription factor 4, transcript variant X2
E2F transcription factor 4, transcript variant X3
E2F transcription factor 4, transcript variant X4
engulfment and cell motility 3, transcript variant X1
engulfment and cell motility protein 3 isoform X1
engulfment and cell motility 3, transcript variant X2
engulfment and cell motility protein 3 isoform X2
uncharacterized protein KIAA0895-like homolog isoform X4
uncharacterized protein KIAA0895-like homolog isoform X3
uncharacterized protein KIAA0895-like homolog isoform X2
uncharacterized protein KIAA0895-like homolog isoform X1
phosphatidylcholine-sterol acyltransferase
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
RHO family interacting cell polarization regulator 1, transcript variant X7
RHO family interacting cell polarization regulator 1, transcript variant X11
RHO family interacting cell polarization regulator 1, transcript variant X2
rho family-interacting cell polarization regulator 1 isoform X2
RHO family interacting cell polarization regulator 1, transcript variant X1
RHO family interacting cell polarization regulator 1, transcript variant X4
RHO family interacting cell polarization regulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
rho family-interacting cell polarization regulator 1 isoform X1
rho family-interacting cell polarization regulator 1 isoform X4
rho family-interacting cell polarization regulator 1 isoform X3
RHO family interacting cell polarization regulator 1, transcript variant X10
RHO family interacting cell polarization regulator 1, transcript variant X5
RHO family interacting cell polarization regulator 1, transcript variant X6
rho family-interacting cell polarization regulator 1 isoform X5
rho family-interacting cell polarization regulator 1 isoform X6
RHO family interacting cell polarization regulator 1, transcript variant X9
RHO family interacting cell polarization regulator 1, transcript variant X8
rho family-interacting cell polarization regulator 1 isoform X7
rho family-interacting cell polarization regulator 1 isoform X8
CCCTC-binding factor, transcript variant X5
CCCTC-binding factor, transcript variant X2
CCCTC-binding factor, transcript variant X3
CCCTC-binding factor, transcript variant X1
CCCTC-binding factor, transcript variant X4
transcriptional repressor CTCF isoform X1
transcriptional repressor CTCF isoform X2
transcriptional repressor CTCF isoform X3
capping protein regulator and myosin 1 linker 2, transcript variant X1
capping protein regulator and myosin 1 linker 2, transcript variant X4
capping protein regulator and myosin 1 linker 2, transcript variant X2
capping protein regulator and myosin 1 linker 2, transcript variant X3
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X1
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X4
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X2
capping protein, Arp2/3 and myosin-I linker protein 2 isoform X3
uncharacterized oxidoreductase C663.06c-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized oxidoreductase C663.09c-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
C-type lectin domain family 18 member A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
zinc finger DHHC-type containing 1, transcript variant X1
zinc finger DHHC-type containing 1, transcript variant X2
tubulin polymerization promoting protein family member 3
tubulin polymerization-promoting protein family member 3
pleckstrin homology and RhoGEF domain containing G4, transcript variant X6
pleckstrin homology and RhoGEF domain containing G4, transcript variant X5
pleckstrin homology and RhoGEF domain containing G4, transcript variant X4
pleckstrin homology and RhoGEF domain containing G4, transcript variant X2
pleckstrin homology and RhoGEF domain containing G4, transcript variant X1
pleckstrin homology and RhoGEF domain containing G4, transcript variant X3
solute carrier family 9 member A5, transcript variant X2
solute carrier family 9 member A5, transcript variant X3
solute carrier family 9 member A5, transcript variant X1
solute carrier family 9 member A5, transcript variant X5
solute carrier family 9 member A5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
11-beta-hydroxysteroid dehydrogenase type 2
SNF-related serine/threonine-protein kinase-like, transcript variant X2
SNF-related serine/threonine-protein kinase-like, transcript variant X1
SNF-related serine/threonine-protein kinase-like
SET domain containing 6, protein lysine methyltransferase
CCR4-NOT transcription complex subunit 1, transcript variant X4
CCR4-NOT transcription complex subunit 1, transcript variant X2
CCR4-NOT transcription complex subunit 1, transcript variant X3
CCR4-NOT transcription complex subunit 1, transcript variant X1
CCR4-NOT transcription complex subunit 1, transcript variant X8
CCR4-NOT transcription complex subunit 1, transcript variant X6
CCR4-NOT transcription complex subunit 1, transcript variant X7
CCR4-NOT transcription complex subunit 1, transcript variant X5
CCR4-NOT transcription complex subunit 1 isoform X8
CCR4-NOT transcription complex subunit 1 isoform X4
CCR4-NOT transcription complex subunit 1 isoform X6
CCR4-NOT transcription complex subunit 1 isoform X2
CCR4-NOT transcription complex subunit 1 isoform X7
CCR4-NOT transcription complex subunit 1 isoform X3
CCR4-NOT transcription complex subunit 1 isoform X5
CCR4-NOT transcription complex subunit 1 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00404
COORDINATES: nucleotide motif:Rfam:12.0:RF00407
solute carrier family 38 member 7, transcript variant X2
solute carrier family 38 member 7, transcript variant X3
solute carrier family 38 member 7, transcript variant X1
solute carrier family 38 member 7, transcript variant X4
putative sodium-coupled neutral amino acid transporter 7 isoform X2
putative sodium-coupled neutral amino acid transporter 7 isoform X1
putative sodium-coupled neutral amino acid transporter 7 isoform X3
aspartate aminotransferase, mitochondrial
cap methyltransferase 2, transcript variant X1
cap methyltransferase 2, transcript variant X2
cap methyltransferase 2, transcript variant X3
cap methyltransferase 2, transcript variant X4
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2
HYDIN axonemal central pair apparatus protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
VAC14 component of PIKFYVE complex, transcript variant X4
VAC14 component of PIKFYVE complex, transcript variant X2
VAC14 component of PIKFYVE complex, transcript variant X3
VAC14 component of PIKFYVE complex, transcript variant X1
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
MTSS I-BAR domain containing 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
MTSS I-BAR domain containing 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
MTSS I-BAR domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
MTSS I-BAR domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
MTSS I-BAR domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
MTSS I-BAR domain containing 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
MTSS I-BAR domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
MTSS I-BAR domain containing 2, transcript variant X1
MTSS I-BAR domain containing 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
splicing factor 3b subunit 3, transcript variant X1
splicing factor 3b subunit 3, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00611
conserved oligomeric Golgi complex subunit 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 2, transcript variant X2
ST3 beta-galactoside alpha-2,3-sialyltransferase 2, transcript variant X1
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2
pyruvate dehydrogenase phosphatase regulatory subunit, transcript variant X3
pyruvate dehydrogenase phosphatase regulatory subunit, transcript variant X4
pyruvate dehydrogenase phosphatase regulatory subunit, transcript variant X2
pyruvate dehydrogenase phosphatase regulatory subunit, transcript variant X1
pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial
golgi glycoprotein 1, transcript variant X2
golgi glycoprotein 1, transcript variant X1
ring finger and WD repeat domain 3, transcript variant X1
ring finger and WD repeat domain 3, transcript variant X2
mixed lineage kinase domain like pseudokinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mixed lineage kinase domain-like protein
WD repeat domain 59, transcript variant X1
WD repeat domain 59, transcript variant X4
WD repeat domain 59, transcript variant X3
WD repeat domain 59, transcript variant X6
WD repeat domain 59, transcript variant X2
WD repeat domain 59, transcript variant X5
zinc and ring finger 1, transcript variant X1
zinc and ring finger 1, transcript variant X2
probable D-lactate dehydrogenase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
BCAR1 scaffold protein, Cas family member, transcript variant X2
BCAR1 scaffold protein, Cas family member, transcript variant X1
breast cancer anti-estrogen resistance protein 1 isoform X2
breast cancer anti-estrogen resistance protein 1 isoform X1
nuclear pore complex protein Nup93 isoform X1
nuclear pore complex protein Nup93 isoform X2
nuclear pore complex protein Nup93 isoform X3
nuclear pore complex protein Nup93 isoform X4
Bardet-Biedl syndrome 2, transcript variant X1
Bardet-Biedl syndrome 2, transcript variant X2
Bardet-Biedl syndrome 2 protein isoform X1
Bardet-Biedl syndrome 2 protein isoform X2
2-oxoglutarate and iron dependent oxygenase domain containing 1, transcript variant X2
2-oxoglutarate and iron dependent oxygenase domain containing 1, transcript variant X1
cleavage and polyadenylation specificity factor subunit 5
G protein subunit alpha o1, transcript variant X2
guanine nucleotide-binding protein G(o) subunit alpha isoform X2
G protein subunit alpha o1, transcript variant X1
guanine nucleotide-binding protein G(o) subunit alpha isoform X1
uncharacterized LOC125332262, transcript variant X3
uncharacterized LOC125332262, transcript variant X1
uncharacterized LOC125332262, transcript variant X2
core-binding factor subunit beta, transcript variant X2
core-binding factor subunit beta, transcript variant X1
core-binding factor subunit beta, transcript variant X3
core-binding factor subunit beta isoform X1
core-binding factor subunit beta isoform X3
core-binding factor subunit beta isoform X2
phagosome assembly factor 1, transcript variant X3
phagosome assembly factor 1, transcript variant X1
phagosome assembly factor 1, transcript variant X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, transcript variant X4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 isoform X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 isoform X2
tumor necrosis factor receptor type 1-associated DEATH domain protein
dynein axonemal assembly factor 1, transcript variant X2
dynein axonemal assembly factor 1, transcript variant X1
dynein axonemal assembly factor 1 isoform X2
dynein axonemal assembly factor 1 isoform X1
hydroxysteroid dehydrogenase like 1, transcript variant X1
inactive hydroxysteroid dehydrogenase-like protein 1 isoform X1
hydroxysteroid dehydrogenase like 1, transcript variant X2
hydroxysteroid dehydrogenase like 1, transcript variant X5
hydroxysteroid dehydrogenase like 1, transcript variant X3
hydroxysteroid dehydrogenase like 1, transcript variant X4
inactive hydroxysteroid dehydrogenase-like protein 1 isoform X2
membrane bound transcription factor peptidase, site 1, transcript variant X2
membrane bound transcription factor peptidase, site 1, transcript variant X1
membrane-bound transcription factor site-1 protease
solute carrier family 38 member 8, transcript variant X1
solute carrier family 38 member 8, transcript variant X2
solute carrier family 38 member 8, transcript variant X3
solute carrier family 38 member 8, transcript variant X4
solute carrier family 38 member 8, transcript variant X7
solute carrier family 38 member 8, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 38 member 8, transcript variant X6
putative sodium-coupled neutral amino acid transporter 8 isoform X1
putative sodium-coupled neutral amino acid transporter 8 isoform X2
putative sodium-coupled neutral amino acid transporter 8 isoform X3
putative sodium-coupled neutral amino acid transporter 8 isoform X4
putative sodium-coupled neutral amino acid transporter 8 isoform X7
putative sodium-coupled neutral amino acid transporter 8 isoform X5
putative sodium-coupled neutral amino acid transporter 8 isoform X6
N-terminal EF-hand calcium binding protein 2, transcript variant X1
N-terminal EF-hand calcium binding protein 2, transcript variant X2
N-terminal EF-hand calcium-binding protein 2 isoform X1
N-terminal EF-hand calcium-binding protein 2 isoform X2
oxidative stress induced growth inhibitor 1, transcript variant X2
oxidative stress induced growth inhibitor 1, transcript variant X1
oxidative stress-induced growth inhibitor 1
receptor-interacting serine/threonine-protein kinase 2-like, transcript variant X2
receptor-interacting serine/threonine-protein kinase 2-like, transcript variant X1
receptor-interacting serine/threonine-protein kinase 2-like
solute carrier family 7 member 6, transcript variant X2
solute carrier family 7 member 6, transcript variant X1
solute carrier family 7 member 6, transcript variant X6
solute carrier family 7 member 6, transcript variant X7
solute carrier family 7 member 6, transcript variant X8
solute carrier family 7 member 6, transcript variant X3
solute carrier family 7 member 6, transcript variant X4
solute carrier family 7 member 6, transcript variant X5
solute carrier family 7 member 6 opposite strand, transcript variant X2
solute carrier family 7 member 6 opposite strand, transcript variant X1
probable RNA polymerase II nuclear localization protein SLC7A6OS isoform X2
probable RNA polymerase II nuclear localization protein SLC7A6OS isoform X1
protein arginine methyltransferase 7, transcript variant X1
protein arginine methyltransferase 7, transcript variant X2
protein arginine N-methyltransferase 7 isoform X1
protein arginine N-methyltransferase 7 isoform X2
sphingomyelin phosphodiesterase 3, transcript variant X1
sphingomyelin phosphodiesterase 3, transcript variant X2
epithelial splicing regulatory protein 2, transcript variant X1
epithelial splicing regulatory protein 2, transcript variant X6
epithelial splicing regulatory protein 2, transcript variant X5
epithelial splicing regulatory protein 2, transcript variant X3
epithelial splicing regulatory protein 2, transcript variant X4
epithelial splicing regulatory protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
epithelial splicing regulatory protein 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
epithelial splicing regulatory protein 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
epithelial splicing regulatory protein 2, transcript variant X2
epithelial splicing regulatory protein 2 isoform X1
epithelial splicing regulatory protein 2 isoform X3
epithelial splicing regulatory protein 2 isoform X2
epithelial splicing regulatory protein 2 isoform X4
epithelial splicing regulatory protein 2 isoform X5
epithelial splicing regulatory protein 2 isoform X6
nuclear factor of activated T cells 3, transcript variant X2
nuclear factor of activated T cells 3, transcript variant X1
nuclear factor of activated T-cells, cytoplasmic 3 isoform X2
nuclear factor of activated T-cells, cytoplasmic 3 isoform X1
dihydrouridine synthase 2, transcript variant X2
dihydrouridine synthase 2, transcript variant X1
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: probable ATP-dependent RNA helicase DDX28
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
dipeptidase 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dipeptidase 2-like, transcript variant X5
dipeptidase 2-like, transcript variant X1
dipeptidase 2-like, transcript variant X2
dipeptidase 2-like, transcript variant X3
dipeptidase 2-like, transcript variant X6
solute carrier family 12 member 4, transcript variant X1
solute carrier family 12 member 4, transcript variant X2
solute carrier family 12 member 4 isoform X1
solute carrier family 12 member 4 isoform X2
solute carrier family 12 member 4, transcript variant X5
solute carrier family 12 member 4 isoform X5
solute carrier family 12 member 4, transcript variant X3
solute carrier family 12 member 4, transcript variant X4
solute carrier family 12 member 4 isoform X3
solute carrier family 12 member 4 isoform X4
sodium-dependent noradrenaline transporter
lysophosphatidylcholine acyltransferase 2
iroquois homeobox 6, transcript variant X2
iroquois homeobox 6, transcript variant X1
iroquois homeobox 6, transcript variant X3
iroquois-class homeodomain protein IRX-6 isoform X3
iroquois-class homeodomain protein IRX-6 isoform X2
iroquois-class homeodomain protein IRX-6 isoform X1
uncharacterized LOC125331995, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
iroquois-class homeodomain protein IRX-5
uncharacterized LOC125331995, transcript variant X5
uncharacterized LOC125331995, transcript variant X4
uncharacterized LOC125331995, transcript variant X10
uncharacterized LOC125331995, transcript variant X8
uncharacterized LOC125331995, transcript variant X3
uncharacterized LOC125331995, transcript variant X12
uncharacterized LOC125331995, transcript variant X13
uncharacterized LOC125331995, transcript variant X6
uncharacterized LOC125331995, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC125331995, transcript variant X14
uncharacterized LOC125331995, transcript variant X1
uncharacterized LOC125331995, transcript variant X9
uncharacterized LOC125331995, transcript variant X7
iroquois-class homeodomain protein IRX-3
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X3
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X1
alpha-ketoglutarate-dependent dioxygenase FTO isoform X3
alpha-ketoglutarate-dependent dioxygenase FTO isoform X1
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X2
alpha-ketoglutarate-dependent dioxygenase FTO isoform X2
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
alpha-ketoglutarate-dependent dioxygenase FTO isoform X4
alpha-ketoglutarate-dependent dioxygenase FTO isoform X5
FTO alpha-ketoglutarate dependent dioxygenase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
alpha-ketoglutarate-dependent dioxygenase FTO isoform X6
uncharacterized LOC125331968, transcript variant X13
uncharacterized LOC125331968, transcript variant X4
uncharacterized LOC125331968, transcript variant X11
uncharacterized LOC125331968, transcript variant X12
uncharacterized LOC125331968, transcript variant X1
uncharacterized LOC125331968, transcript variant X6
uncharacterized LOC125331968, transcript variant X5
uncharacterized LOC125331968, transcript variant X3
uncharacterized LOC125331968, transcript variant X10
uncharacterized LOC125331968, transcript variant X7
uncharacterized LOC125331968, transcript variant X8
uncharacterized LOC125331968, transcript variant X9
uncharacterized LOC125331968, transcript variant X14
uncharacterized LOC125331968, transcript variant X16
uncharacterized LOC125331968, transcript variant X17
uncharacterized LOC125331968, transcript variant X2
uncharacterized LOC125331968, transcript variant X15
AKT interacting protein, transcript variant X3
AKT interacting protein, transcript variant X2
AKT interacting protein, transcript variant X1
chromodomain helicase DNA binding protein 9, transcript variant X7
chromodomain helicase DNA binding protein 9, transcript variant X4
chromodomain helicase DNA binding protein 9, transcript variant X6
chromodomain helicase DNA binding protein 9, transcript variant X5
chromodomain helicase DNA binding protein 9, transcript variant X1
chromodomain helicase DNA binding protein 9, transcript variant X2
chromodomain helicase DNA binding protein 9, transcript variant X3
chromodomain helicase DNA binding protein 9, transcript variant X8
chromodomain helicase DNA binding protein 9, transcript variant X9
chromodomain-helicase-DNA-binding protein 9 isoform X5
chromodomain-helicase-DNA-binding protein 9 isoform X2
chromodomain-helicase-DNA-binding protein 9 isoform X4
chromodomain-helicase-DNA-binding protein 9 isoform X3
chromodomain-helicase-DNA-binding protein 9 isoform X1
chromodomain-helicase-DNA-binding protein 9 isoform X6
chromodomain-helicase-DNA-binding protein 9 isoform X7
TOX high mobility group box family member 3, transcript variant X1
TOX high mobility group box family member 3, transcript variant X3
TOX high mobility group box family member 3 isoform X1
TOX high mobility group box family member 3 isoform X3
TOX high mobility group box family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
TOX high mobility group box family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
TOX high mobility group box family member 3, transcript variant X5
TOX high mobility group box family member 3 isoform X2
TOX high mobility group box family member 3 isoform X4
TOX high mobility group box family member 3 isoform X5
spalt like transcription factor 1, transcript variant X2
spalt like transcription factor 1, transcript variant X1
uncharacterized LOC125332182, transcript variant X3
uncharacterized LOC125332182, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC125332182, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC125332182, transcript variant X5
uncharacterized LOC125332182, transcript variant X4
uncharacterized LOC125332183, transcript variant X2
uncharacterized LOC125332183, transcript variant X6
uncharacterized LOC125332183, transcript variant X4
uncharacterized LOC125332183, transcript variant X1
uncharacterized LOC125332183, transcript variant X3
uncharacterized LOC125332183, transcript variant X5
CYLD lysine 63 deubiquitinase, transcript variant X2
CYLD lysine 63 deubiquitinase, transcript variant X1
ubiquitin carboxyl-terminal hydrolase CYLD isoform X2
ubiquitin carboxyl-terminal hydrolase CYLD isoform X1
NKD inhibitor of WNT signaling pathway 1, transcript variant X3
NKD inhibitor of WNT signaling pathway 1, transcript variant X2
NKD inhibitor of WNT signaling pathway 1, transcript variant X1
protein naked cuticle homolog 1 isoform X3
protein naked cuticle homolog 1 isoform X1
protein naked cuticle homolog 1 isoform X2
adenylate cyclase 7, transcript variant X4
adenylate cyclase 7, transcript variant X3
adenylate cyclase 7, transcript variant X1
adenylate cyclase 7, transcript variant X2
HEAT repeat containing 3, transcript variant X1
HEAT repeat containing 3, transcript variant X2
HEAT repeat-containing protein 3 isoform X1
HEAT repeat-containing protein 3 isoform X2
CTD nuclear envelope phosphatase 1 regulatory subunit 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
CTD nuclear envelope phosphatase 1 regulatory subunit 1, transcript variant X2
CTD nuclear envelope phosphatase 1 regulatory subunit 1, transcript variant X1
nuclear envelope phosphatase-regulatory subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 423, transcript variant X1
zinc finger protein 423, transcript variant X2
zinc finger protein 423, transcript variant X3
zinc finger protein 423, transcript variant X4
NEDD4 binding protein 1, transcript variant X2
NEDD4 binding protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
NEDD4 binding protein 1, transcript variant X1
siah E3 ubiquitin protein ligase 1, transcript variant X1
siah E3 ubiquitin protein ligase 1, transcript variant X3
siah E3 ubiquitin protein ligase 1, transcript variant X2
E3 ubiquitin-protein ligase SIAH1 isoform X2
E3 ubiquitin-protein ligase SIAH1 isoform X1
phosphorylase kinase regulatory subunit beta, transcript variant X5
phosphorylase kinase regulatory subunit beta, transcript variant X3
phosphorylase kinase regulatory subunit beta, transcript variant X2
phosphorylase kinase regulatory subunit beta, transcript variant X4
phosphorylase kinase regulatory subunit beta, transcript variant X6
phosphorylase kinase regulatory subunit beta, transcript variant X1
phosphorylase b kinase regulatory subunit beta isoform X3
phosphorylase b kinase regulatory subunit beta isoform X4
phosphorylase b kinase regulatory subunit beta isoform X1
phosphorylase b kinase regulatory subunit beta isoform X2
integrin alpha FG-GAP repeat containing 1
DnaJ heat shock protein family (Hsp40) member A2
myosin light chain kinase 3, transcript variant X3
myosin light chain kinase 3, transcript variant X4
myosin light chain kinase 3, transcript variant X1
myosin light chain kinase 3, transcript variant X2
origin recognition complex subunit 6, transcript variant X2
origin recognition complex subunit 6, transcript variant X1
origin recognition complex subunit 6 isoform X2
origin recognition complex subunit 6 isoform X1
VPS35 retromer complex component, transcript variant X1
vacuolar protein sorting-associated protein 35 isoform X1
VPS35 retromer complex component, transcript variant X2
vacuolar protein sorting-associated protein 35 isoform X2
VPS35 retromer complex component, transcript variant X4
VPS35 retromer complex component, transcript variant X3
vacuolar protein sorting-associated protein 35 isoform X3
cytochrome b-c1 complex subunit Rieske, mitochondrial
V-set and transmembrane domain containing 2B
V-set and transmembrane domain-containing protein 2B
POP4 homolog, ribonuclease P/MRP subunit
pleckstrin homology and FYVE domain containing 1, transcript variant X1
pleckstrin homology and FYVE domain containing 1, transcript variant X2
pleckstrin homology domain-containing family F member 1
chromosome 12 C19orf12 homolog, transcript variant X3
chromosome 12 C19orf12 homolog, transcript variant X1
chromosome 12 C19orf12 homolog, transcript variant X2
chromosome 12 C19orf12 homolog, transcript variant X4
uncharacterized protein F13E9.13, mitochondrial-like, transcript variant X3
uncharacterized protein F13E9.13, mitochondrial-like, transcript variant X1
uncharacterized protein F13E9.13, mitochondrial-like, transcript variant X2
uncharacterized protein F13E9.13, mitochondrial-like isoform X1
uncharacterized protein F13E9.13, mitochondrial-like isoform X3
uncharacterized protein F13E9.13, mitochondrial-like isoform X2
unconventional prefoldin RPB5 interactor 1
zinc finger protein 536, transcript variant X4
zinc finger protein 536, transcript variant X5
zinc finger protein 536, transcript variant X1
zinc finger protein 536, transcript variant X7
zinc finger protein 536, transcript variant X6
zinc finger protein 536, transcript variant X8
zinc finger protein 536, transcript variant X10
zinc finger protein 536, transcript variant X11
zinc finger protein 536, transcript variant X12
zinc finger protein 536, transcript variant X3
zinc finger protein 536, transcript variant X2
zinc finger protein 536, transcript variant X9
bcl-2-binding component 3, isoforms 3/4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
zinc finger protein 507, transcript variant X1
zinc finger protein 507, transcript variant X2
dpy-19 like C-mannosyltransferase 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
dpy-19 like C-mannosyltransferase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
dpy-19 like C-mannosyltransferase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
dpy-19 like C-mannosyltransferase 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
dpy-19 like C-mannosyltransferase 3, transcript variant X1
dpy-19 like C-mannosyltransferase 3, transcript variant X2
probable C-mannosyltransferase DPY19L3 isoform X1
probable C-mannosyltransferase DPY19L3 isoform X2
probable C-mannosyltransferase DPY19L3 isoform X3
ankyrin repeat domain 27, transcript variant X1
ankyrin repeat domain 27, transcript variant X2
ankyrin repeat domain 27, transcript variant X5
ankyrin repeat domain 27, transcript variant X3
ankyrin repeat domain 27, transcript variant X4
ankyrin repeat domain-containing protein 27
ankyrin repeat domain 27, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ankyrin repeat domain 27, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
regulator of G protein signaling 9 binding protein
regulator of G-protein signaling 9-binding protein
tudor domain containing 12, transcript variant X1
tudor domain containing 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125332167, transcript variant X2
putative ATP-dependent RNA helicase TDRD12 isoform X1
putative ATP-dependent RNA helicase TDRD12 isoform X3
tudor domain containing 12, transcript variant X2
uncharacterized LOC125332167, transcript variant X1
putative ATP-dependent RNA helicase TDRD12 isoform X2
synaptic vesicle membrane protein VAT-1 homolog-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X3
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X1
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X10
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X12
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X11
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X9
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X8
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X7
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X4
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X5
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X2
hypoxanthine-guanine phosphoribosyltransferase-like, transcript variant X6
hypoxanthine-guanine phosphoribosyltransferase-like
ADAM metallopeptidase with thrombospondin type 1 motif 18, transcript variant X1
A disintegrin and metalloproteinase with thrombospondin motifs 18 isoform X1
ADAM metallopeptidase with thrombospondin type 1 motif 18, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 18 isoform X2
ADAM metallopeptidase with thrombospondin type 1 motif 18, transcript variant X3
A disintegrin and metalloproteinase with thrombospondin motifs 18 isoform X3
uncharacterized LOC125332226, transcript variant X2
uncharacterized LOC125332226, transcript variant X3
uncharacterized LOC125332226, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
thymidine kinase 2, transcript variant X2
thymidine kinase 2, transcript variant X1
thymidine kinase 2, mitochondrial isoform X2
thymidine kinase 2, mitochondrial isoform X1
CKLF like MARVEL transmembrane domain containing 3
CKLF-like MARVEL transmembrane domain-containing protein 3
CKLF like MARVEL transmembrane domain containing 4, transcript variant X2
CKLF like MARVEL transmembrane domain containing 4, transcript variant X1
CKLF-like MARVEL transmembrane domain-containing protein 4 isoform X2
CKLF-like MARVEL transmembrane domain-containing protein 4 isoform X1
dynein cytoplasmic 1 light intermediate chain 2, transcript variant X1
cytoplasmic dynein 1 light intermediate chain 2 isoform X1
dynein cytoplasmic 1 light intermediate chain 2, transcript variant X2
cytoplasmic dynein 1 light intermediate chain 2 isoform X2
telomere repeat binding bouquet formation protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
telomere repeats-binding bouquet formation protein 1
NEDD8-activating enzyme E1 regulatory subunit
pyruvate dehydrogenase phosphatase catalytic subunit 2, transcript variant X1
pyruvate dehydrogenase phosphatase catalytic subunit 2, transcript variant X2
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 2, mitochondrial
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
cytosolic iron-sulfur assembly component 2B
carboxylesterase 2, transcript variant X2
carboxylesterase 2, transcript variant X3
carboxylesterase 2, transcript variant X1
fatty acyl-CoA hydrolase precursor, medium chain-like
ubiquitin like modifier activating enzyme 2, transcript variant X1
ubiquitin like modifier activating enzyme 2, transcript variant X2
SUMO-activating enzyme subunit 2 isoform X1
SUMO-activating enzyme subunit 2 isoform X2
WT1 interacting protein, transcript variant X1
Wilms tumor protein 1-interacting protein isoform X1
WT1 interacting protein, transcript variant X3
Wilms tumor protein 1-interacting protein isoform X3
WT1 interacting protein, transcript variant X4
WT1 interacting protein, transcript variant X2
Wilms tumor protein 1-interacting protein isoform X2
uncharacterized LOC125332103, transcript variant X1
uncharacterized LOC125332103, transcript variant X3
uncharacterized LOC125332103, transcript variant X4
uncharacterized LOC125332103, transcript variant X2
Wilms tumor protein 1-interacting protein isoform X4
granule associated Rac and RHOG effector 1, transcript variant X2
granule associated Rac and RHOG effector 1, transcript variant X1
granule associated Rac and RHOG effector 1, transcript variant X3
granule associated Rac and RHOG effector protein 1
LSM14A mRNA processing body assembly factor, transcript variant X2
LSM14A mRNA processing body assembly factor, transcript variant X1
LSM14A mRNA processing body assembly factor, transcript variant X3
transcription initiation factor TFIID subunit 4-like
LOW QUALITY PROTEIN: transcription initiation factor TFIID subunit 4-like
potassium channel tetramerization domain containing 15, transcript variant X3
potassium channel tetramerization domain containing 15, transcript variant X2
potassium channel tetramerization domain containing 15, transcript variant X4
potassium channel tetramerization domain containing 15, transcript variant X1
potassium channel tetramerization domain containing 15, transcript variant X5
BTB/POZ domain-containing protein KCTD15 isoform X2
BTB/POZ domain-containing protein KCTD15 isoform X1
BTB/POZ domain-containing protein KCTD15 isoform X3
BTB/POZ domain-containing protein KCTD15 isoform X4
carbohydrate sulfotransferase 8, transcript variant X2
carbohydrate sulfotransferase 8, transcript variant X3
carbohydrate sulfotransferase 8, transcript variant X5
carbohydrate sulfotransferase 8, transcript variant X6
carbohydrate sulfotransferase 8, transcript variant X1
carbohydrate sulfotransferase 8, transcript variant X4
carbohydrate sulfotransferase 8, transcript variant X10
carbohydrate sulfotransferase 8, transcript variant X8
carbohydrate sulfotransferase 8, transcript variant X9
carbohydrate sulfotransferase 8, transcript variant X7
carbohydrate sulfotransferase 8 isoform X2
carbohydrate sulfotransferase 8 isoform X1
carbohydrate sulfotransferase 8 isoform X4
carbohydrate sulfotransferase 8 isoform X3
carbohydrate sulfotransferase 8, transcript variant X12
carbohydrate sulfotransferase 8, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
carbohydrate sulfotransferase 8, transcript variant X13
CCAAT enhancer binding protein gamma, transcript variant X1
CCAAT enhancer binding protein gamma, transcript variant X2
solute carrier family 7 member 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
solute carrier family 7 member 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
solute carrier family 7 member 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
asc-type amino acid transporter 1 isoform X1
asc-type amino acid transporter 1 isoform X3
asc-type amino acid transporter 1 isoform X2
LDL receptor related protein 3, transcript variant X1
LDL receptor related protein 3, transcript variant X2
LDL receptor related protein 3, transcript variant X3
low-density lipoprotein receptor-related protein 3 isoform X1
low-density lipoprotein receptor-related protein 3 isoform X2
low-density lipoprotein receptor-related protein 3 isoform X3
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
G-patch domain containing 1, transcript variant X2
G-patch domain containing 1, transcript variant X1
G patch domain-containing protein 1 isoform X2
G patch domain-containing protein 1 isoform X1
FA core complex associated protein 24, transcript variant X2
FA core complex associated protein 24, transcript variant X1
rhophilin Rho GTPase binding protein 2, transcript variant X2
rhophilin Rho GTPase binding protein 2, transcript variant X1
Fanconi anemia core complex-associated protein 24
centrosomal protein 89, transcript variant X5
centrosomal protein 89, transcript variant X1
centrosomal protein 89, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
centrosomal protein 89, transcript variant X4
centrosomal protein of 89 kDa isoform X1
centrosomal protein of 89 kDa isoform X2
centrosomal protein of 89 kDa isoform X4
centrosomal protein 89, transcript variant X3
centrosomal protein of 89 kDa isoform X3
centrosomal protein of 89 kDa isoform X5
solute carrier family 7 member 9, transcript variant X1
B(0,+)-type amino acid transporter 1 isoform X1
solute carrier family 7 member 9, transcript variant X2
B(0,+)-type amino acid transporter 1 isoform X2
peroxisomal coenzyme A diphosphatase NUDT7
uncharacterized LOC125332021, transcript variant X4
uncharacterized LOC125332021, transcript variant X3
uncharacterized LOC125332021, transcript variant X1
uncharacterized LOC125332021, transcript variant X2
serine/threonine-protein kinase pim-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125332019, transcript variant X4
uncharacterized LOC125332019, transcript variant X3
uncharacterized LOC125332019, transcript variant X1
uncharacterized LOC125332019, transcript variant X2